Literature DB >> 9853436

Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants.

.   

Abstract

BACKGROUND: Early elective surgery may prevent rupture of abdominal aortic aneurysms, but mortality is 5-6%. The risk of rupture seems to be low for aneurysms smaller than 5 cm. We investigated whether prophylactic open surgery decreased long-term mortality risks for small aneurysms.
METHODS: We randomly assigned 1090 patients aged 60-76 years, with symptomless abdominal aortic aneurysms 4.0-5.5 cm in diameter to undergo early elective open surgery (n=563) or ultrasonographic surveillance (n=527). Patients were followed up for a mean of 4.6 years. If the diameter of aneurysms in the surveillance group exceeded 5.5 cm, surgical repair was recommended. The primary endpoint was death. Mortality analyses were done by intention to treat.
FINDINGS: The two groups had similar cardiovascular risk factors at baseline. 93% of patients adhered to the assigned treatment. 309 patients died during follow-up. The overall hazard ratio for all-cause mortality in the early-surgery group compared with the surveillance group was 0.94 (95% CI 0.75-1.17, p=0.56). The 30-day operative mortality in the early-surgery group was 5.8%, which led to a survival disadvantage for these patients early in the trial. Mortality did not differ significantly between groups at 2 years, 4 years, or 6 years. Age, sex, or initial aneurysm size did not modify the overall hazard ratio.
INTERPRETATION: Ultrasonographic surveillance for small abdominal aortic aneurysms is safe, and early surgery does not provide a long-term survival advantage. Our results do not support a policy of open surgical repair for abdominal aortic aneurysms of 4.0-5.5 cm in diameter.

Entities:  

Mesh:

Year:  1998        PMID: 9853436

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  170 in total

1.  When it is inflamed, it hurts.

Authors:  R Baliga; J Narula
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

2.  Fitness to drive: a survey of the knowledge and practice of vascular surgeons regarding patients with carotid disease and aortic aneurysms.

Authors:  W B Campbell; M Schuijtvlot; K L Allington; J J Earnshaw
Journal:  Ann R Coll Surg Engl       Date:  2002-03       Impact factor: 1.891

3.  Accelerated publication versus usual publication in 2 leading medical journals.

Authors:  William A Ghali; Jacques Cornuz; Finlay A McAlister; Jean-Blaise Wasserfallen; P J Devereaux; C David Naylor
Journal:  CMAJ       Date:  2002-04-30       Impact factor: 8.262

4.  [Duplex ultrasound of arteries and veins. II: Retroperitoneal blood vessels, pelvic and leg arteries, veins].

Authors:  A Strauss
Journal:  Radiologe       Date:  2002-03       Impact factor: 0.635

5.  Screening men for aortic aneurysm.

Authors:  Roger M Greenhalgh; Janet T Powell
Journal:  BMJ       Date:  2002-11-16

6.  Abdominal Aortic Aneurysms.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-06

Review 7.  Recent developments in vascular surgery.

Authors:  Jeremy Crane; Nick Cheshire
Journal:  BMJ       Date:  2003-10-18

8.  Early surgery or surveillance for small abdominal aortic aneurysms?

Authors:  Kathryn A Myers
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

Review 9.  CT screening: a trade-off of risks, benefits, and costs.

Authors:  M G Myriam Hunink; G Scott Gazelle
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Impact of contrast injection and stent-graft implantation on reproducibility of volume measurements in semiautomated segmentation of abdominal aortic aneurysm on computed tomography.

Authors:  Florence Morin-Roy; Claude Kauffmann; An Tang; Sofiane Hadjadj; Olivier Thomas; Nicolas Piché; Stéphane Elkouri; Dan Yang Yang; Éric Therasse; Gilles Soulez
Journal:  Eur Radiol       Date:  2014-05-07       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.